
This lecture series was instituted by Dr. Arindam Nath Bose (BT/CHE/1975) in memory of his late father, Shri Arabindo Nath Bose, who established the department of Food Technology at Jadavpur University in Calcutta in early 1950s. Dr. Arindam Nath Bose received a Master's degree from the University of Michigan, in 1975 and a PhD in Chemical Engineering from Purdue University. In 1977. Prof. Bose has over three decades long career in the biopharmaceutical industry including positions in bioprocess development, clinical supply manufacturing, corporate biotechnology strategy and advocacy for science-based regulations for biologics. He also served as Vice-President, External Affairs and Biosimilar Strategy for the Biotherapeutics Pharmaceutical Sciences organization of Pfizer Worldwide R&D. At Pfizer, his group focused on biopharmaceutical product development outsourcing, competitive intelligence and external influencing in addition to developing and executing Pfizer's entry strategy for biosimilars.
Dr. Anil Koul spoke on 'Discovery of Bedaquiline and Its Impact on the Global TB Landscape' on February 21, 2025. Dr. Koul is the Vice President of Global Public Health at Johnson & Johnson and also serves as a Board Member and Professor of Translational Discovery at LSHTM. With over 25 years of experience in pharmaceutical drug discovery and early clinical development, he has successfully advanced projects from initial drug discovery stages to human studies. His PhD and early training were at the Max Planck Institute in Germany in the lab of 'Lasker Award' winner Prof Axel Ullrich.At Johnson & Johnson, Dr. Koul has led innovation-driven, cost-effective R&D programs and previously served on the Board of Janssen Pharmaceuticals, Belgium. With expertise across infectious diseases, neuroscience, and oncology, he has worked on small molecules, biologics, microbiome, and AI platforms.